Dechra Pharmaceuticals plc Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Dechra Pharmaceuticals plc's estimated annual revenue is currently $322M per year.(i)
  • Dechra Pharmaceuticals plc's estimated revenue per employee is $201,000

Employee Data

  • Dechra Pharmaceuticals plc has 1602 Employees.(i)
  • Dechra Pharmaceuticals plc grew their employee count by 13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.4M470%N/AN/A
#2
$26.3M131-13%N/AN/A
#3
$6.2M31-6%N/AN/A
#4
$27.7M138-14%N/AN/A
#5
$5.4M270%N/AN/A
#6
$68.3M340-1%N/AN/A
#7
$22.1M1104%N/AN/A
#8
$12.3M858%$20MN/A
#9
$3.6M18-22%N/AN/A
#10
$5M2532%N/AN/A
Add Company

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. \n\nWe have offices across 24 countries in Europe and North America, we export to over 50 countries worldwide and have six manufacturing sites. The Dechra Group employ over one thousand people and our revenue in 2018 reached £407.1m. \n\nOur six Dechra Values: Dedication, Enjoyment, Courage, Honesty, Relationships and Ambition reflect the best aspects of behaviour and competence in Dechra. We embrace the values at every level of the business and everything about the business is underpinned by our values. How we talk to the people that matter, the way we always look to do things better and how we think of the people and the animals beyond the product.\n\nWe are active in Companion Animal, Equine and Food Producing Animal products. \n\nOur key focus therapeutic areas are: \n• Endocrinology \n• Dermatology \n• Anaesthesia and Analgesia \n• Water Medication\n• Diets and Nutrition\n• Equine Locomotion \n\nAnd we support our clients in practice with a wide range of materials and technical advice.\n\nFollow us on Twitter - @Dechra

keywords:N/A

N/A

Total Funding

1602

Number of Employees

$322M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dechra Pharmaceuticals plc News

2022-04-20 - Pet Veterinary Drug Market Size, Scope And Forecast ...

... Bayer AG, Merck Animal Health, Elanco Animal Health Inc., Virbac Group, Ceva, Dechra Pharmaceuticals Plc, Vetoquinol, Orion Corporation.

2022-04-13 - Dechra Pharmaceuticals (OTCMKTS:DCHPF) Sees ...

Dechra Pharmaceuticals PLC is a holding company, which engages in the veterinary pharmaceuticals and related products business.

2022-04-06 - Insiders of Dechra Pharmaceuticals PLC (LON:DPH) would have made a tidy sum after selling UK£1.8m worth of stock at a high price

Last week, Dechra Pharmaceuticals PLC's (LON:DPH) stock jumped 4.0%, but insiders who sold UK£1.8m worth of stock in over the past year are...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$471.9M22766%$4.5M
#2
$1074.5M23407%N/A
#3
$682.1M32482%N/A
#4
$1771.1M3857N/AN/A
#5
$1520M660710%$2.6B